Amendment clarifies the deadline for filing patent term extension applications covering drug products that must be approved by the FDA.

Purpose:

An amendment numbered 9 printed in Part B of House Report 112-111 to restore language for calculation of 60-day period for application of patent term extension that the managers amendment strikes.

House Amendment Code:

(A009)

House Tally Clerks use this code to manage amendment information.